Alto Neuroscience (ANRO) Institutional Ownership $4.31 +0.22 (+5.38%) (As of 11/22/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Alto Neuroscience (NYSE:ANRO)Number ofInstitutional Buyers(last 12 months)26TotalInstitutional Inflows(last 12 months)$73.37MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$5.05M Get ANRO Insider Trade Alerts Want to know when executives and insiders are buying or selling Alto Neuroscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ANRO Institutional Buying and Selling by Quarter Ad Darwin2025: Digital Asset Insights You Need to KnowCryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.Get your guide today! Alto Neuroscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC29,599$339K0.0%+872.7%0.110% 11/16/2024 Geode Capital Management LLC469,988$5.38M0.0%+148.7%1.743% 11/15/2024 Barclays PLC29,599$339K0.0%+872.7%0.110% 11/15/2024 Jane Street Group LLC10,817$124K0.0%N/A0.040% 11/15/2024 Wellington Management Group LLP60,636$694K0.0%N/A0.225% 11/15/2024 State Street Corp236,857$2.71M0.0%+123.7%0.878% Get the Latest News and Ratings for ANRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 RA Capital Management L.P.2,075,154$23.74M0.3%-0.5%7.694% 11/15/2024 Philadelphia Financial Management of San Francisco LLC449,952$5.15M0.8%+1.5%1.668% 11/15/2024 Point72 Asset Management L.P.977,692$11.19M0.0%-6.9%3.625% 11/14/2024 Fred Alger Management LLC181,435$2.08M0.0%+56.1%0.673% 11/14/2024 Vestal Point Capital LP650,000$7.44M0.6%+4.8%2.411% 11/14/2024 MetLife Investment Management LLC12,783$146K0.0%N/A0.047% 11/13/2024 BNP Paribas Financial Markets4,315$49K0.0%+619.2%0.016% 11/13/2024 FMR LLC2,363,056$27.03M0.0%+1.4%8.765% 11/13/2024 The Manufacturers Life Insurance Company 65,805$753K0.0%+84.5%0.244% 11/13/2024 Bowie Capital Management LLC19,484$223K0.0%-54.9%0.072% 11/12/2024 Charles Schwab Investment Management Inc.186,968$2.14M0.0%+182.5%0.694% 11/12/2024 Board of Trustees of The Leland Stanford Junior University79,740$912K0.1%-76.8%0.296% 11/8/2024 Jennison Associates LLC832,290$9.52M0.0%+80.3%3.087% 8/19/2024 Point72 Asset Management L.P.1,050,037$11.23M0.0%-6.7%3.906% 8/14/2024 Fred Alger Management LLC116,254$1.24M0.0%-1.5%0.432% 8/8/2024 Federated Hermes Inc.12,000$128K0.0%+33.3%0.045% 8/6/2024 Bowie Capital Management LLC43,186$462K0.0%N/A0.161% 8/3/2024 TD Asset Management Inc86,792$928K0.0%N/A0.323% 8/1/2024 Rhumbline Advisers10,539$113K0.0%N/A0.039% 7/26/2024 Bank of New York Mellon Corp23,557$252K0.0%N/A0.088% 5/17/2024 RA Capital Management L.P.1,385,491$21.27M0.3%N/A5.154% 5/17/2024 Artal Group S.A.350,000$5.37M0.1%N/A1.302% 5/17/2024 Zimmer Partners LP75,000$1.15M0.0%N/A0.279% 5/16/2024 AWM Investment Company Inc.299,147$4.59M0.6%N/A1.113% 5/15/2024 Price T Rowe Associates Inc. MD637,604$9.79M0.0%N/A2.372% 5/10/2024 Vanguard Group Inc.536,332$8.23M0.0%N/A1.995% 5/2/2024 Jennison Associates LLC458,599$7.04M0.0%N/A1.706% 4/30/2024 University of Texas Texas AM Investment Managment Co.22,175$340K0.1%N/A0.082% (Data available from 1/1/2016 forward) ANRO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ANRO shares? During the previous two years, 28 institutional investors and hedge funds held shares of Alto Neuroscience. The most heavily invested institutionals were FMR LLC ($27.03M), RA Capital Management L.P. ($23.74M), Point72 Asset Management L.P. ($11.19M), Price T Rowe Associates Inc. MD ($9.79M), Jennison Associates LLC ($9.52M), Vanguard Group Inc. ($8.23M), and Vestal Point Capital LP ($7.44M).Learn more on ANRO's institutional investors. Which institutional investors have been buying Alto Neuroscience stock? Of the 26 institutional investors that purchased Alto Neuroscience stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($1.39M), Jennison Associates LLC ($829.21K), Price T Rowe Associates Inc. MD ($637.60K), Vanguard Group Inc. ($536.33K), Artal Group S.A. ($350K), AWM Investment Company Inc. ($299.15K), and Geode Capital Management LLC ($281.02K). How much institutional buying is happening at Alto Neuroscience? Institutional investors have bought a total of 5,139,898 shares in the last 24 months. This purchase volume represents approximately $73.37M in transactions. Which Alto Neuroscience major shareholders have been selling company stock? The following institutional investors have sold Alto Neuroscience stock in the last 24 months: Board of Trustees of The Leland Stanford Junior University ($264.27K), Point72 Asset Management L.P. ($147.31K), Bowie Capital Management LLC ($23.70K), RA Capital Management L.P. ($10.40K), and Fred Alger Management LLC ($1.76K). How much institutional selling is happening at Alto Neuroscience? Institutional investors have sold a total of 447,445 shares in the last 24 months. This volume of shares sold represents approximately $5.05M in transactions. Related Companies Acelyrin Institutional Ownership Foghorn Therapeutics Institutional Ownership Cartesian Therapeutics Institutional Ownership Aquestive Therapeutics Institutional Ownership Canopy Growth Institutional Ownership KalVista Pharmaceuticals Institutional Ownership Akebia Therapeutics Institutional Ownership Larimar Therapeutics Institutional Ownership Tango Therapeutics Institutional Ownership Verve Therapeutics Institutional Ownership This page (NYSE:ANRO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANRO Stock Alerts